Natasha Sumner

Natasha Sumner

Husch Blackwell LLP

Contact
View Bio
RSS

Latest Posts › Center for Drug Evaluation and Research (CDER)

Share:

Psychedelic Breakthroughs: Key Considerations for Clinical Trials

Psychedelics have the potential to treat chronic conditions such as post-traumatic stress disorder (PTSD), depression, obsessive-compulsive disorder (OCD), fibromyalgia, and various behavioral health conditions, yet...more

1/26/2024  /  Center for Drug Evaluation and Research (CDER) , Clinical Trials , DEA , Food and Drug Administration (FDA) , Investigational New Drug Application (IND) , Life Sciences , Medical Foods , Plant Based Products
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide